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1. INTRODUCTION 
Type II collagen is the major collagen of car- 
tilage. However, new collagenous chains have been 
described in different cartilaginous tissues, re- 
cently. The la, 2a and 3a chains were extracted 
from human and bovine hyaline cartilage [1]. 
Other minor collagenous components were extrac- 
ted from neonatal pig and human cartilage noted 
M, CFI, CF2 [2-4], from bovine nasal cartilage 
and human intervertebral disc noted CPS1, CPS2 
[5,6] and from chicken sternal cartilage noted 
HMW, LMW [7,8] and M 1, M 2 [9]. 
Here, we report the partial characterization f 3 
collagenous fractions obtained after limited pepsin 
treatment of foetal calf cartilage and isolated ac- 
cording to their solubility properties. The 1.2 M 
NaC1 fraction contains the la, 2t~ and 3a chains. 
The 2.0 M NaC1 and 3.0 M NaCl fractions contain 
at least 7 collagenous chains, which are related to 
the disulfide-bonded new chains enumerated 
above, but show some major differences, Anti- 
bodies against he 1.2 M and 2.0 M NaC1 fractions 
were raised in rabbits and their specificity tested 
by radioimmunoprecipitation. The localization of 
the corresponding collagenous chains was 
achieved by indirect immunofluorescence in epi- 
physeal proper and growth cartilage from foetal 
calf cartilage. 
2. MATERIALS AND METHODS 
2.1. Preparation and purification of collagens 
Epiphyseal cartilage was obtained from foetal 
calves (7-9 months). Thin tissue slices were ho- 
mogenized under liquid nitrogen. Proteoglycans 
were extracted with 4 M guanidinium chloride, 
pepsin treatment and precipitation of the pepsin- 
soluble fraction were performed as in [1]. Salt frac- 
tionation of the collagenous components was 
achieved as in [2,3]. For further purification the 
different fractions (1.2 M, 2.0 M and 3.0 M NaCI) 
were passed down a DEAE-cellulose column un- 
der native conditions [2] to remove contaminating 
acidic glycoproteins. 
2.2. Biochemical characterization 
SDS-polyacrylamide gel electrophoresis was 
performed as in [10] with 6.75% acrylamide gels, 
with and without reduction with dithiothreitol 
(DTT). Apparent Mr values were calculated by 
comparison to fill and a 1 components of type I 
collagen and cyanogen bromide peptides of the al 
(I) chain. For molecular sieve chromatography, 
samples were chromatographed on an agarose 
(Biogel A-1.5 m; 200--400 mesh, Biorad) column 
(2.5 × 220 cm) eluted with 1 M CAC12-0.05 M 
Tris (pH 7.5) at 20 ml/h. 
Amino acid analyses were carried out on a Jeol- 
5AH automatic analyzer after hydrolysis of sam- 
ples with 6 N HCI for 24 h at 110°C. 
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2.3. Preparation and purification of antibodies 
New Zealand white adult rabbits were injected 
intradermally with 1 mg antigen in 0.5 M acetic 
acid emulsified with an equal volume of Freund's 
complete adjuvant. Two, 4 and 6 weeks after the 
initial injection, intradermal booster injection of 
1 mg antigen in 0.5 M acetic acid emulsified with 
Freund's incomplete adjuvant was administered. 
The antibodies were purified by immunoadsorp- 
tion on affinity columns composed of bovine types 
I and II collagens and of 1.2 M and 2.0 M NaC1 
fractions conjugated to glutaraldehyde-activated 
Ultrogel ACA 22 resin. 
2.4. Radioimmunoprecipitation 
Collagens were labelled with 1251 by the lacto-~ 
peroxidase method [11] and radioimmunoprecipi- 
tation was performed as in [11]. The binding of 
125I-collagen to antibody was expressed as a per- 
centage of the added collagen found in the precipi- 
tate. 
2.5. Immunofluorescence staining procedure 
Fresh frozen sections (6~tm) of epiphyseal 
proper and growth cartilage from foetal calf were 
treated with bovine testicular hyaluronidase for 2 h 
at 37°C. Indirect immunofluorescence technique 
was performed as follows: the sections were ex- 
posed to purified anticollagen antibodies for 
20 min at room temperature, treated with FITC- 
conjugated goat antiserum against rabbit IgG (In- 
stitut Pasteur Production) and observed on a 
Leitz-Dialux fluorescence microscope. 
3. RESULTS AND DISCUSSION 
3.1. Characterization fcollagenous fractions 
3.1.1. 1.2 M NaCI fraction 
This fraction, precipitated at 1.2 M NaC1 in 
0.5 M acetic acid contains 3 chains with electro- 
phoretic (fig.la) and compositional properties (not 
shown) similar to the la, 2a and 3a chains de- 
scribed in [ 1]. 
3.1.2. 2.0 M and 3.0 M NaC1 fractions 
The 2.0 M NaCI fraction reveals at least 7 bands 
(called XI-X7 chains) on SDS--polyacrylamide 
gel electrophoresis (fig.lb,c) whereas the 3.0M 
NaC1 fraction contains only the low Mr chains 
(Xs-XT). The two fractions comprise -5% of the 
total collagen in foetal calf and human cartilage 
but their amount decreases with ageing of tissue. 
Chain X3 was described in all preparations but 
the relative amounts of the X1 and X 2 chains de- 
pended upon the conditions of pepsin treatment 
(fig.lb,c). The X 3 chain of 125 000 M r was isolated 
by chromatography on Biogel-A 1.5 m (fig.2, peak 
2 consistent with Mr 125 000). With reduction the 
X3 chain gave rise to at least 3 major components 
(fig.le,i) called X3R1, X3R 2 and X3R 3 of 40 000, 
37 000 and 31 000 Mr. The electrophoretic be- 
haviour and the amino acid composition (table 1) 
of the X3 chain are similar to those reported for 
the collagenous components M [2,3], CPSI [5,6], 
I-IMW [7,8] and M1 [9]. However, with reduction 
M and CPSI both give rise to only one chain of 
33 000 Mr. The X3 chain can rather be compared 
to HMW [7,8] or MI [9] giving rise with reduction, 
respectively, to 3 and 4 components but with dif- 
ferent Mr-values. 
Observed in addition to the X3 chain, the X1 
and X2 chains of 180 000 and 160 000 Mr were elu- 
ted as a single peak on Biogel A-I.5 m (fig.2, peak 
1) consistent with 180 000 Mr. However, SDS- 
polyacrylamide gel electrophoresis of the material 
corresponding tothis peak revealed that an impor- 
tant amount of the X3 chain was eluted with the 
XI and X2 chains. With reduction, in addition to 
the 3 components arising from the X3 chain (fig. 1 i) 
two further products of 50 000 and 62 500 Mr were 
observed (fig. I h). 
The X4 chain (fig.If,j) is a disulfide-bonded col- 
lagenous fragment, of 31 500 Mr by SDS-poly- 
acrylamide gel electrophoresis and 33 000 Mr by 
molecular sieve chromatography, which can be 
compared to CF2 [3], CPS2 [6], LMW [7,8] and M2 
[9]. With reduction the X4 chain gave rise to one 
component of 13 000 Mr. The amino acid composi- 
tion of the X4 chain (table 1) is different from that 
reported for CF2 [3] and is rather similar to that of 
CPS2 [6], LMW [7] and M2 [9]. In particular the X4 
chain contains much less hydroxyproline and pro- 
line (110 and 116 residues/1000) than CF2 (198.5 
and 146.8 residues/1000). 
The Xs, X6 and X7 chains (fig.lg,k,l) obtained in 
higher yields in the 3.0 M NaCI fraction are non 
disulfide-bonded components of 19 500, 15 000 
and 13 000 Mr. They were eluted as a single peak 
on Biogel A-I.5 m (fig.2, peak 4) consistent with 
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Fig.l. SDS-polyacrylamide g l (6.75%) electrophoresis, without and with (+ DTT) reduction: (a) of the 1.2 M NaC1 
fraction; (b,c) of two different preparations of the 2.0 M NaC1 fraction; (d-k) of the material recovered from agarose 
gel filtration and corresponding tothe 4 peaks of the chromatogram presented in fig. 2; (e) of the 3.0 M NaC1 fraction. 
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Fig.2. Agarose (Biogel A-1.5 m) molecular sieve elution 
pattern of the 2.0 M NaCI fraction. The column (2.5 x 
200 cm) was eluted with 1 M CaC12 in 50 mM Tris-HC1 
(pH 7.5) at 20 ml/h. Arrows show the elution position of 
fl and a components of type I collagen and the bars 
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Fig.3. Reactions of rabbit antisera to; (a) 1.2 M NaC1 
and (b) 2.0 M NaC1 fractions with labelled collagens. 
The 125I-labeUed antigens used were: the (.) 1.2 M 
NaC1 fraction, (,) 2.0 M NaC1 fraction and (o) type I 
and (~) type II bovine collagens. 
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Fig.4. Epiphyseal proper (a,b) and growth (c,d) cartilage from foetal calf after hyaluronidase treatment, stained with 
anti-i.2 M NaC1 fraction (la, 2a, 3a chains) antibodies (a,c) and with anti-2.0 M NaCI fraction (XI-X 7 chains) anti- 
bodies (b,d). Specific staining with both antibodies can be detected on the pericellular surface of chondrocytes from the 
two different zones of the epiphyseal cartilage. 
17 000 Mr. The amino acid composition of these 
chains (table 1) shows a very high content of pro- 
line and hydroxyproline (159 and 160 residues/ 
1000), similar to that reported for CFI and CF2 [3] 
and for C4 [8]. 
It is now important o determine if these 7 
chains (or fragments) are parts of a single molecule 
of collagen. The presence of higher yields of Xs, 
X6 and X7 chains in the more soluble fraction is in 
favour of the existence of at least 2 different mo- 
lecular species as already suggested for M, CFI, 
CF2 [2,3] and CPSt, CPS2 [4,5]. These molecules 
may belong to a unique large molecule analogous 
to type IV collagen, whose 'four domain struc- 
ture' [12] includes triple helical and non-col- 
lagenous (pepsin-sensitive) segments cross-linked 
or not by disulfide bridges or other covalent bonds. 
3.2. Characterization of antibodies and immuno- 
fluorescent localization 
The two collagenous fractions were immunogens 
in rabbits and induced antisera with good binding 
capacity after 3 injections. Following purification 
the antibodies showed typical binding profiles with 
125I-labelled antigens (fig.3). High concentration 
of antiserum bound 70-90% of the labelled anti- 
gen, indicating that iodination had not destroyed 
antigenicity. Both antisera showed a strong reac- 
tion for the immunizing antigen and a weak one 
with the other collagenous fraction and with 
bovine types I and II collagens. 
Anti 1.2 M NaC1 and 2.0 M NaC1 fractions gave 
an intense staining located around the chondrocyte 
lacunae from both the epiphyseal proper and 
growth cartilage (fig.4). The labelling of the anti 
2.0 M NaC1 fraction seemed to be more restricted 
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Table 1 
Amino acid composition (residues/1000) of the compo- 
nents recovered from agarose gel filtration (fig.2) 
Peak : 1 2 3 4 
Chains : XI,X2,X3 X3 X4 X5,X6,X7 
4 Hyp 102 85 110 165 
Asp 41 45 50 34 
Thr 17 18 20 20 
Ser 33 35 42 23 
Glu 105 109 89 57 
Pro 100 101 116 160 
Gly 325 330 301 331 
Ala 49 49 54 33 
Cys 7 nd nd nd 
Val 37 38 31 28 
Met 9 12 nd nd 
lie 23 22 25 27 
Leu 43 46 47 47 
Tyr 4 3 1 0 
Phe 6 5 7 5 
Hyl 25 28 32 9 
Lys 15 14 30 35 
His 6 7 9 1 
Arg 53 53 36 25 
around the chondrocytes than the anti 1.2 M NaC1 
fraction which gave a more diffuse fluorescent 
ring. Anti 1.2 M NaC1 fraction (la, 2a, 3ct chains) 
did not stain the extracellular matrix. If the struc- 
ture of the 3a chain is similar to that of the a t (II) 
chain as postulated [13] the fraction of the anti- 
bodies directed against 3a chain may have been 
eliminated u~ing the immunoadsorption step on 
type II collagen or this 3a chain is far less immu- 
nogen than la and 2a chains. 
A similar immunolocalization was obtained with 
related collagenous fractions [2,4] and with type V 
collagen [14]. Nevertheless we failed to show the 
presence of type V collagen by classical biochemi- 
cal methods. The labelling observed in [14] may be 
due to a cross-reactivity of anti-type V antibodies 
with the la, 2a chains and/or with the 2.0 M NaC1 
fraction. Indeed biochemical properties of l a, 2a 
chains are similar to type V collagen chains [1,6]. 
The protease susceptibility of the la, 2a chains and 
HMW fraction was similar to that of type V col- 
lagen in [13,15]. 
The chondrocytes appear to be surrounded by an 
exocytoskeleton including o e or several new col- 
lagens whose molecular composition and organiza- 
tion remain to be established. 
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